Breaking News

No fix in sight for surprise ambulance bills; Sen. Baldwin criticizes Ascension’s investments

February 13, 2023
Alex Hogan/ STAT

Patients still have no protection against surprise ambulance bills. And there's no solution in sight

Ambulances were excluded from the federal law that banned most types of surprise medical bills, and there's no solution in sight.

By Bob Herman


Sen. Tammy Baldwin criticizes Ascension's for-profit investment activities, requests returns and fees info

Sen. Tammy Baldwin on Monday blasted Ascension for service cuts at hospitals in Wisconsin and questioned its investment activities.

By Rachel Cohrs


Watch: Blockbuster drug Humira has new competition. Here's why that matters

Humira has been the world's best selling medicine since it arrived on the market in 2002. Now, it is finally getting competition.

By Alex Hogan and Ed Silverman



Adobe

Survey: Nearly 3 in 5 teen girls felt persistently sad or hopeless in 2021

The nearly 3 in 5 teen girls who felt persistently sad or hopeless in 2021 was a 60% increase compared to a decade earlier.

By Andrew Joseph


STAT+ | In another pharma shakeup, Sanofi loses top executive known for overhauling R&D

Sanofi head of R&D John Reed is leaving the pharmaceutical giant to pursue a new opportunity, the company announced Monday.

By Allison DeAngelis and Matthew Herper


Opinion: ChatGPT-assisted diagnosis: Is the future suddenly here?

For online diagnosis, ChatGPT outperformed Google search and symptom checkers, and came close to diagnoses from real physicians.

By Ruth Hailu and Andrew Beam and Ateev Mehrotra


Researchers have designed an ingestible device that doctors can monitor as it moves through the GI tract.
Courtesy Caltech and MIT

Could a swallowable, quarter-sized device make diagnosing GI diseases less unpleasant?

Researchers have designed an ingestible device that doctors can monitor as it moves through the gastrointestinal tract.

By Lizzy Lawrence


'It is a balance': Scientists grapple with ethics of cutting-edge stem cell research

"You don't ban nuclear physics because somebody can make a nuclear bomb," said one speaker. "There's a benefit that you regulate."

By Jonathan Wosen


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments